Page 4 of 8 – SEC Filing 1 NAMES OF REPORTING PERSON Douglas L. Braunstein 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐ 3 SEC USE ONLY 4 SOURCE OF FUNDS
AF 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ☐ 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER
0 8 SHARED VOTING POWER
1,882,494 9 SOLE DISPOSITIVE POWER
0 10 SHARED DISPOSITIVE POWER
1,882,494 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,882,494 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 4.98%(3) 14 TYPE OF REPORTING PERSON
IN
(3) The percentage calculations herein are based upon an aggregate of 37,812,869 shares of common stock, par value $.001 per share, of AtriCure, Inc. outstanding as of the completion of AtriCure, Inc.’s offering of common stock on or about October 10, 2018, as reported in AtriCure, Inc.’s prospectus supplement filed pursuant to Rule 424(b)(5) on October 5, 2018.
Follow Atricure Inc. (NASDAQ:ATRC)
Follow Atricure Inc. (NASDAQ:ATRC)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
1 | NAMES OF REPORTING PERSON Douglas L. Braunstein | |||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) ☐ (b) ☐ | ||
3 | SEC USE ONLY | |||
4 | SOURCE OF FUNDS AF | |||
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) | ☐ | ||
6 | CITIZENSHIP OR PLACE OF ORGANIZATION United States | |||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER 0 | ||
8 | SHARED VOTING POWER 1,882,494 | |||
9 | SOLE DISPOSITIVE POWER 0 | |||
10 | SHARED DISPOSITIVE POWER 1,882,494 | |||
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,882,494 | |||
12 | CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES | ☐ | ||
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 4.98%(3) | |||
14 | TYPE OF REPORTING PERSON IN |
(3) | The percentage calculations herein are based upon an aggregate of 37,812,869 shares of common stock, par value $.001 per share, of AtriCure, Inc. outstanding as of the completion of AtriCure, Inc.’s offering of common stock on or about October 10, 2018, as reported in AtriCure, Inc.’s prospectus supplement filed pursuant to Rule 424(b)(5) on October 5, 2018. |